Concero Inc (CERO) Stock
CERO is no longer traded. Concero was delisted from the Nasdaq in August 2024.
Prices on this page are historical; the last trade was August 30, 2024 at $0.13.
Concero stock price history
CERO final trading statistics
- Final close
- $0.13
- Final trading day
- Aug 30, 2024
- Market cap at delisting
- $6.52M
- Shares outstanding
- 51.35M
- Final 52-week range
- $0.12 – $12.80
- Avg. volume (final 3 mo.)
- 5,281,330
- All-time high (split-adj.)
- $53.50 · Mar 2000
- All-time low (split-adj.)
- $0.13 · Aug 2024
- Return since IPO
- -95.2%
- Beta
- -0.42
- Book value / share
- -$0.52
- Price / book
- -0.24
Concero annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | — | -$2.5M | -$0.38 |
| FY2022 | $0.00 | -$667.7K | -$0.06 |
| FY2021 | $0.00 | -$315.5K | -$0.01 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Concero Inc
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
Concero stock FAQ
What happened to Concero stock?
Concero stock was delisted from the Nasdaq. Its final close was $0.13 on August 30, 2024.
Is CERO stock still trading?
No. CERO was delisted from the Nasdaq in August 2024 and no longer trades on a U.S. exchange.
What was the last price of CERO stock?
CERO closed at $0.13 on its final trading day, August 30, 2024, for a market value of about $6.52M.
What were Concero's revenue and earnings in its last full fiscal year?
Concero reported revenue of — and net income of -$2.5M in fiscal 2023, its last full year as a public company.
When did Concero go public?
Concero Inc stock began trading on February 15, 2024.